0001144204-16-124265.txt : 20160916 0001144204-16-124265.hdr.sgml : 20160916 20160916161524 ACCESSION NUMBER: 0001144204-16-124265 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160915 FILED AS OF DATE: 20160916 DATE AS OF CHANGE: 20160916 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EYEGATE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001372514 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 271 WAVERLEY OAKS ROAD STREET 2: SUITE 108 CITY: WALTHAM STATE: MA ZIP: 02452 BUSINESS PHONE: 781-788-9043 MAIL ADDRESS: STREET 1: 271 WAVERLEY OAKS ROAD STREET 2: SUITE 108 CITY: WALTHAM STATE: MA ZIP: 02452 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FROM STEPHEN CENTRAL INDEX KEY: 0001620137 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36672 FILM NUMBER: 161889574 MAIL ADDRESS: STREET 1: C/O BURNS & LEVINSON LLP STREET 2: 125 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02110 4 1 v448959_4.xml OWNERSHIP DOCUMENT X0306 4 2016-09-15 0 0001372514 EYEGATE PHARMACEUTICALS INC EYEG 0001620137 FROM STEPHEN C/O EYEGATE PHARMACEUTICALS, INC. 271 WAVERLEY OAKS ROAD, SUITE 108 WALTHAM MA 02452 1 1 0 0 President and CEO Common Stock 2016-09-15 4 P 0 15000 1.4892 A 139965 D The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.479 to $1.509, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4. /s/ J. Fraser Collin, attorney-in-fact 2016-09-16